ABBVIE INC. vs. Corcept Therapeutics Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 7 of 9 compared factors.
Size & Scale
| ABBV | CORT | |
|---|---|---|
| Market Cap | $439.59 billion | $12.13 billion |
| Revenue (TTM) | $64.39 billion | $741.17 million |
| Net Income (TTM) | $6.32 billion | $106.11 million |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | CORT | |
|---|---|---|
| P/E Ratio | 70.47 | 131.57 |
| Price / Book | -74.66 | 19.19 |
| Price / Sales | 6.83 | 16.36 |
ABBV leads on 3 of 3 valuation factors.
Profitability
| ABBV | CORT | |
|---|---|---|
| Net Margin | 9.81% | 14.32% |
| Return on Equity | -107.29% | 16.79% |
CORT leads on 2 of 2 profitability factors.
Dividend
| ABBV | CORT | |
|---|---|---|
| Dividend Yield | 2.77% | — |
| Payout Ratio | 195.48 | — |
ABBV and CORT split the dividend factors evenly.
Risk & Sentiment
| ABBV | CORT | |
|---|---|---|
| Short Interest | 0.85% | 16.06% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, CORT overview, CORT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.